» Authors » Florence Deauvieau

Florence Deauvieau

Explore the profile of Florence Deauvieau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 372
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Deauvieau F, Fenis A, Dalencon F, Burdin N, Vivier E, Kerdiles Y
Curr Top Microbiol Immunol . 2015 Sep; 395:173-90. PMID: 26385768
Since their discovery in the late 1970s, in vivo studies on mouse natural killer (NK) cell almost entirely relied on the use of depleting antibodies and were associated with significant...
2.
Deauvieau F, Ollion V, Doffin A, Achard C, Fonteneau J, Verronese E, et al.
Int J Cancer . 2014 Jul; 136(5):1085-94. PMID: 25046660
Dendritic cells (DCs) cross-present antigen (Ag) to initiate T-cell immunity against most infections and tumors. Natural killer (NK) cells are innate cytolytic lymphocytes that have emerged as key modulators of...
3.
Balas C, Kennel A, Deauvieau F, Sodoyer R, Arnaud-Barbe N, Lang J, et al.
J Infect Dis . 2010 Dec; 203(1):103-8. PMID: 21148502
DNA microarrays were used to assess the innate gene signature in human myeloid dendritic cells infected with chimeric dengue 1-4 vaccines, a wild-type dengue 3 virus, or a classically attenuated...
4.
Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, et al.
J Immunol . 2010 Jul; 185(4):2080-8. PMID: 20639488
Cross-talk between NK cells and dendritic cells (DCs) is critical for the potent therapeutic response to dsRNA, but the receptors involved remained controversial. We show in this paper that two...
5.
Deauvieau F, Dussurgey S, Rossignol D, De Montfort A, Burdin N, Guy B
Vaccine . 2009 Nov; 28(2):576-82. PMID: 19878751
We have conducted a 1-year longitudinal study in mice vaccinated by free serotype 4 Streptococcus pneumoniae PS (PS4), the corresponding tetanus toxoid (TT)-conjugated vaccine, or the TT carrier alone. B...
6.
Deauvieau F, Sanchez V, Balas C, Kennel A, De Montfort A, Lang J, et al.
Am J Trop Med Hyg . 2007 Jan; 76(1):144-54. PMID: 17255244
Dengue infection is an important public health issue worldwide. The ChimeriVax-Dengue (CYD) vaccine uses yellow fever (YF) 17D vaccine as a live vector. Dendritic cells (DCs) play a key role...
7.
Sanchez V, Gimenez S, Tomlinson B, Chan P, Neil Thomas G, Forrat R, et al.
Vaccine . 2006 Apr; 24(23):4914-26. PMID: 16632108
VDV3, a clonal derivative of the Mahidol live-attenuated dengue 3 vaccine was prepared in Vero cells. Despite satisfactory preclinical evaluation, VDV3 was reactogenic in humans. We explored whether immunological mechanisms...
8.
Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates E, et al.
J Exp Med . 2005 Apr; 201(9):1435-46. PMID: 15851485
Dendritic cells (DC) produce interleukin-12 (IL-12) in response to Toll-like receptor (TLR) activation. Two major TLR signaling pathways participate in the response to pathogens: the nuclear factor-kappaB (NF-kappaB)-dependent pathway leading...